Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
McKesson
Colorcon
Moodys
Merck

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for TEVA PHARMACEUTICALS USA, INC. v. SEBELIUS (D.C. 2009)

See Plans and Pricing

« Back to Dashboard

TEVA PHARMACEUTICALS USA, INC. v. SEBELIUS (D.C. 2009)

Docket   Start Trial Date Filed 2009-06-17
Court District Court, District of Columbia Date Terminated 2009-07-31
Cause 05:702 Administrative Procedure Act Assigned To Rosemary M. Collyer
Jury Demand None Referred To
Parties KATHLEEN SEBELIUS; MARGARET HAMBURG; TEVA PHARMACEUTICALS USA, INC.; UNITED STATES FOOD AND DRUG ADMINISTRATION
Patents 5,138,069; 5,153,197; 5,608,075
Attorneys Drake S. Cutini; Gregory L. Skidmore; Jay P. Lefkowitz; Michael D. Shumsky
Firms Kirkland & Ellis LLP
Link to Docket External link to docket
Small Molecule Drugs cited in TEVA PHARMACEUTICALS USA, INC. v. SEBELIUS
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for TEVA PHARMACEUTICALS USA, INC. v. SEBELIUS (D.C. 2009)

Date Filed Document No. Description Snippet Link To Document
2009-07-31 20 provided patent information to the FDA for listing in the Orange Book: (1) U.S. Patent No. 5,138,069 (“the…the ’069 patent”); (2) U.S. Patent No. 5,153,197 (“the ’197 patent”); 4 The FDA has…to the ’069 patent and the ’197 patent and a paragraph IV certification to the ’075 patent. Teva sent …’075 patent is a polymorph patent. Teva’s Mot. for Prelim. Inj. [Dkt. # 5] at 27 (the ’075 patent is titled… withdrawal of a patent as a basis for its drug(s) (i.e., a request that the patent be “delisted”) triggers External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
AstraZeneca
Medtronic
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.